1. Home
  2. CCO vs SVRA Comparison

CCO vs SVRA Comparison

Compare CCO & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.38

Market Cap

1.0B

ML Signal

HOLD

SVRA

Savara Inc.

BUY

Current Price

$5.60

Market Cap

1.1B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CCO
SVRA
Founded
1995
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
CCO
SVRA
Price
$2.38
$5.60
Analyst Decision
Hold
Buy
Analyst Count
6
9
Target Price
$2.10
$7.33
AVG Volume (30 Days)
6.8M
1.4M
Earning Date
02-26-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,569,344,000.00
N/A
Revenue This Year
$6.76
N/A
Revenue Next Year
$4.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
54.21
N/A
52 Week Low
$0.81
$1.89
52 Week High
$2.39
$7.01

Technical Indicators

Market Signals
Indicator
CCO
SVRA
Relative Strength Index (RSI) 64.15 49.23
Support Level $2.06 $5.10
Resistance Level $2.30 $5.44
Average True Range (ATR) 0.10 0.35
MACD 0.03 0.01
Stochastic Oscillator 97.71 52.33

Price Performance

Historical Comparison
CCO
SVRA

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: